Cysteine cathepsins as a prospective target for anticancer therapies—current progress and prospects
Abstract
No abstract availableKeywords
This publication has 279 references indexed in Scilit:
- Overexpression of Cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinomaBMC Surgery, 2013
- Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline)Cancer Letters, 2011
- The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot studyBritish Journal of Cancer, 2011
- Using Proteomic Approach to Identify Tumor-Associated Proteins as Biomarkers in Human Esophageal Squamous Cell CarcinomaJournal of Proteome Research, 2011
- Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermisOncogene, 2009
- Frequent loss of cystatin E/M expression implicated in the progression of prostate cancerOncogene, 2009
- Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9Nature Immunology, 2008
- Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomasLaboratory Investigation, 2008
- Inactivation of the cystatin E/M tumor suppressor gene in cervical cancerGenes, Chromosomes and Cancer, 2008
- Cigarette smoke condensate increases cathepsin-mediated invasiveness of oral carcinoma cellsToxicology Letters, 2007